P01.36. Assessment of commercial formulations of mucuna pruriens seeds for Levodopa (L-DOPA) content

by Soumyanath A, Denne T, Peterson A, Shinto L
Published 2012-06-01

P02.183. Comparing the bioavailability of two forms of lipoic acid in multiple sclerosis

by Salinthone S, Yadav V, Ganesh M, Cherala G, Shinto L, Koop D, Bourdette D, Carr D
Published 2012-06-01

P02.08. Patient reported outcomes from complementary, alternative, and integrative medicine (PROCAIM): a feasibility practice network study

by Ackerman D, Shinto L, Hardy M, Heyman A, Nguyen L, Senders A, Abrams D, Ali A, Enebo B, Homel P, Horowitz R, Reardon M, Torkelson C
Published 2012-06-01